{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:55:43Z","timestamp":1762865743422},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T00:00:00Z","timestamp":1290643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrneph.2010.153","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T14:10:42Z","timestamp":1290694242000},"page":"696-698","source":"Crossref","is-referenced-by-count":11,"title":["Do mTOR inhibitors still have a future in ADPKD?"],"prefix":"10.1038","volume":"6","author":[{"given":"Norberto","family":"Perico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,25]]},"reference":[{"key":"BFnrneph2010153_CR1","first-page":"502","volume-title":"Diseases of the Kidney and Urinary Tract","author":"T Ecder","year":"2007","unstructured":"Ecder, T.  et al. in Diseases of the Kidney and Urinary Tract (ed. Schrier, R. W.) 502\u2013539 (Lippincott Williams & Wilkins, Philadelphia, 2007)."},{"key":"BFnrneph2010153_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"BFnrneph2010153_CR3","first-page":"S93","volume":"63","author":"JJ Grantham","year":"1997","unstructured":"Grantham, J. J. Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int. Suppl. 63, S93\u2013S97 (1997).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2010153_CR4","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M.  et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2010153_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000104818","volume":"30","author":"M Wu","year":"2007","unstructured":"Wu, M.  et al. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press. Res. 30, 253\u2013259 (2007).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph2010153_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1681\/ASN.2007050626","volume":"19","author":"Q Qian","year":"2008","unstructured":"Qian, Q.  et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J. Am. Soc. Nephrol. 19, 631\u2013638 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010153_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G.  et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010153_CR8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L.  et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010153_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1681\/ASN.2009121302","volume":"21","author":"N Perico","year":"2010","unstructured":"Perico, N.  et al. Sirolimus therapy to halt the progression of ADPKD. J. Am. Soc. Nephrol. 21, 1031\u20131040 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010153_CR10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2215\/CJN.02251205","volume":"1","author":"L Antiga","year":"2006","unstructured":"Antiga, L.  et al. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report. Clin. J. Am. Soc. Nephrol. 1, 754\u2013760 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:33:39Z","timestamp":1684470819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrneph2010153"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.153","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}